Create an Account
  1. Home
  2. CME
  3. Ophthalmology

KOL Knockout™ Cataract Edition — More than Best Corrected Visual Acuity: Meeting Patient Refractive Expectations - Round 1

KOL Knockout Cataract Edition More than Best Corrected Visual Acuity Meeting Patient Refractive Expectations Round 1
Media formats available:
Details
Presenters

  • Overview

    This popular CME program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the first of three rounds features Taj Nasser, MD; Julie Schallhorn, MD, MS; and F. Beau Swann, MD, MS, as contestants. 

    Dr. Williamson presents complex cataract surgery case studies and the KOLs weigh in on their preferred treatment option, leaving the audience to vote on the winner! 

    There will be learning, laughter, and only one KOL left standing! 

    This content was captured during a live-virtual symposium. Voting took place during the symposium.

     

    This activity is supported by an independent educational grant from Alcon and Johnson & Johnson. 

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Explain how ocular surface disease may affect biometric measurements and postoperative refractive outcomes
    • Compare current and emerging premium IOLs and summarize the latest data on potential outcomes achieved with different IOL technologies
    • Discuss updates in surgical planning systems and new technologies used to improve refractive outcomes and provide better surgical efficiency during refractive cataract surgery
    • Evaluate the potential benefits and drawbacks of using femtosecond laser technology for refractive cataract surgery

  • Accreditation

    Provided by Evolve Medical Education 

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Participation Method

    In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

  • Faculty and Disclosures

    Blake K. Williamson, MD, MPH, MS

    Blake K. Williamson, MD, MPH, MS

    Managing Partner
    Williamson Eye Center and
    Outpatient Surgery Center for Sight
    Baton Rouge, LA

     

    Taj Nasser, MD

    Taj Nasser, MD

    Mueller Vision

    Tylock-George Eyecare
    Fort Worth, TX

     

    Julie Schallhorn, MD, MS

    Julie Schallhorn, MD, MS

    University of California, San Francisco
    San Francisco, CA

     

    F. Beau Swann, MD, MS

    F. Beau Swann, MD, MS

    Brazos Eye Surgery of Texas
    Waco, TX

     

    DISCLOSURE POLICY
    It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

    The following faculty/staff members have the following financial relationships with ineligible companies.

    Blake K. Williamson, MD, MPH, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Bausch + Lomb, BioTissue, Carl Zeiss Meditec, Diopsys, Eyevance, Glaukos, Johnson & Johnson Vision, New World Medical, Omeros, Shire, Sight Sciences, and Sun Pharma. Speaker’s Bureau: AbbVie, Allergan, Glaukos, New World Medical, and TearLab.

    Taj Nasser, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, STAAR Surgical, and Tarsus Pharmaceuticals. Grant/Research Support: STAAR Surgical.

    Julie Schallhorn, MD, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Carl Zeiss Meditec, Elios, and Vialase. Stock/Shareholder: JelliSee, Journey 1, Long Bridge, Neurotrigger, and Novus.

    F. Beau Swann, MD, MS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, BioTissue, Johnson & Johnson Vision, and Ocular Therapeutix. Shareholder: Ocular Theraputix. Speaker's Bureau: Bausch + Lomb, BioTissue, Johnson & Johnson Vision, and Ocular Therapeutix.

    The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.

  • Disclaimer

    OFF-LABEL STATEMENT
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    DISCLAIMER
    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Alcon, or Johnson & Johnson. 

    This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We're glad to see you're enjoying Eye Health Academy…
    but how about a more personalized experience?

    Register for free